MANA-412

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameMANA-412
Drug Alias NameMANA-412
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMana Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMana Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A